S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Ondine Biomedical Share Forecast, Price & News

GBX 43.50
0.00 (0.00%)
(As of 07/4/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1,748 shs
Average Volume
52,743 shs
Market Capitalization
£84.64 million
P/E Ratio
Dividend Yield
Price Target

Ondine Biomedical MarketRank™ Forecast

Analyst Rating
Short Interest
Dividend Strength
News Sentiment
Insider Trading
Proj. Earnings Growth

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.22 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive OBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter.

About Ondine Biomedical

Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; OND1002, a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and OND1003, a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.

OBI Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Year Founded


Pretax Margin


Sales & Book Value

Annual Sales
£2.57 million
Cash Flow
GBX 0.41 per share
Book Value
GBX 15.20 per share


Free Float
Market Cap
£84.64 million
Not Optionable

Ondine Biomedical Frequently Asked Questions

How has Ondine Biomedical's stock performed in 2022?

Ondine Biomedical's stock was trading at GBX 42 on January 1st, 2022. Since then, OBI shares have increased by 3.6% and is now trading at GBX 43.50.
View the best growth stocks for 2022 here

Who are Ondine Biomedical's key executives?

Ondine Biomedical's management team includes the following people:
  • Ms. Carolyn M. Cross C.F.A., CFA, M.B.A., MBA, Founder, CEO & Director
  • Dr. Nicolas G. Loebel Ph.D., Pres, CTO & Director
  • Mr. Thomas Dawson, Sr. VP of Corp. Devel.
  • Mr. Vipul Shah, VP & CFO
  • Mr. Mike Long, VP of Operations

What is Ondine Biomedical's stock symbol?

Ondine Biomedical trades on the London Stock Exchange (LON) under the ticker symbol "OBI."

How do I buy shares of Ondine Biomedical?

Shares of OBI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Ondine Biomedical's stock price today?

One share of OBI stock can currently be purchased for approximately GBX 43.50.

How much money does Ondine Biomedical make?

Ondine Biomedical (LON:OBI) has a market capitalization of £84.64 million and generates £2.57 million in revenue each year.

How can I contact Ondine Biomedical?

The official website for Ondine Biomedical is www.ondinebio.com. The company can be reached via phone at 604-669-0555.

This page (LON:OBI) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.